Moffitt Medical GroupSenior Adult Oncology Program 12902 Usf Magnolia Dr, Tampa, FL 33612 8137456769 (phone), 8137453730 (fax)
Education:
Medical School New York University School of Medicine Graduated: 1980
Procedures:
Chemotherapy
Conditions:
Melanoma Rectal, Abdomen, Small Intestines, or Colon Cancer Abdominal Hernia Acute Pancreatitis Acute Renal Failure
Languages:
English Spanish
Description:
Dr. Weber graduated from the New York University School of Medicine in 1980. He works in Tampa, FL and specializes in Medical Oncology. Dr. Weber is affiliated with Moffitt Cancer Center.
Dr. Weber graduated from the Pennsylvania State University College of Medicine in 1993. He works in Ephrata, PA and specializes in Family Medicine. Dr. Weber is affiliated with WellSpan Ephrata Community Hospital.
Mr. Weber works in Raleigh, NC and 1 other location and specializes in Pain Management. Mr. Weber is affiliated with Duke Raleigh Hospital and Wakemed Raleigh Campus.
Geoffrey Nichol - Short Hills NJ, US Michael Yellin - Upper Montclair NJ, US Steven Fischkoff - Short Hills NJ, US Jeffrey Weber - Los Angeles CA, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The invention provides methods for predicting responsiveness of a subject to therapy with a CTLA-4 blocking agent. The methods involve assaying for at least one CTLA-4 polymorphism in the subject and predicting responsiveness of the subject to therapy with a CTLA-4 blocking agent based on presence or absence of a CTLA-4 polymorphic allele in the subject. The methods can further comprise selecting a treatment regimen with a CTLA-4 blocking agent in a subject based upon presence or absence of a CTLA-4 polymorphic allele in the subject. The methods can further comprise administering a CTLA-4 blocking agent to the subject according to the selected treatment regimen. Kits comprising a CTLA-4 blocking agent and means for assaying one or more CTLA-4 polymorphisms, optionally including a vaccine, are also provided.
Gladys Sierra-Gomez - Woodbridge NJ, US Eva Peters - Cedar Grove NJ, US Thomas Tedeschi - Brewster NY, US Jeffrey Weber - Lake Zurich IL, US Stuart Paterson - Fox River Grove IL, US
International Classification:
B65D 17/34
US Classification:
220359200, 220270000
Abstract:
A polygonal shaped container is provided which includes a wrapper surrounding a food product. The shape of the container is defined by either a frame containing a food product or rigid material incorporated with the wrapper. Access to contents in the container is provided by withdrawing a resealable sealing layer sealed to the top or side surface of the container and withdrawing the sealing layer from the container or by pivoting a rigid lid away from the top of the container.
Structure-Based, Ligand Activity Prediction Using Binding Mode Prediction Information
- Armonk NY, US Jeffrey Kurt Weber - Brooklyn NY, US Sugato Bagchi - White Plains NY, US Wendy Dawn Cornell - Warren NJ, US
International Classification:
G16B 15/30 G06N 3/04 G06N 3/08
Abstract:
A system and method for structure-based, small molecule activity prediction using binding mode prediction information. Binding scores between ligands and target molecules, (e.g. proteins, RNA, DNA, lipids, sugars) are first generated using molecular docking. A first machine learned deep neural network (DNN) model is developed using data representing the molecular ligand-target pair 3D structures and docking features to predict binding modes. Using transfer learning, weights of layers learned in the first machine learned model are used as weights in layers of a second machine learned DNN model used to more accurately improve the performance of activity prediction of the second machine learned model. For a target newly paired ligand-target complex, the method further implements a binding mode selector for selecting one or more particular binding poses for input to the activity prediction model for use in activity mode prediction of an activity of the target paired ligand-protein complex.
Target Molecule-Ligand Binding Mode Prediction Combining Deep Learning-Based Informatics With Molecular Docking
A computer-implemented method is described. The method includes generating, by a ligand bond graph generator, a first graph based on bond connectivity within a ligand molecule that is specified as input. The method further includes generating, by a ligand-protein graph generator, a second graph based on a contact map of the ligand molecule and a target molecule that is specified as another input. The method further includes receiving docking prediction metrics for the ligand molecule and the target molecule. The method further includes inputting, to a deep neural network, as input features, the first graph, the second graph, and the docking prediction metrics. The method further includes determining, using the deep neural network, a binding mode prediction that characterizes a set of potential interactions between the ligand molecule and the target molecule.
- East Hanover NJ, US Ronald H. Exner - Munich, DE Ying (Lora) Liang - East Hanover NJ, US Jeffrey T. Weber - Deerfield IL, US Paul A. Zerfas - East Hanover NJ, US Evan Michael Ziolkowski - Deerfield IL, US
International Classification:
B65D 77/20
Abstract:
A multi-layer film and a film package made from the film are described herein that provide resealing capabilities by utilizing a tacky layer within the multi-layer film. The multi-layer film can include an outer film portion including the embedded tacky layer and an inner film portion. An opening feature formed in the multi-layer film includes a flap configured to be manipulated by a user to create an opening through the multi-layer film. The inner film portion can include a release layer configured specifically to interact with the tacky layer to provide a desired separation peel force and resealing functionalities. The outer film portion can include an outer film layer disposed on an opposite side of the tacky layer from the release layer that is configured to permanently adhere to the tacky layer.
Packages Having Separable Sealing Features And Methods Of Manufacturing
- East Hanover NJ, US Ronald H. Exner - East Hanover NJ, US Jeffrey T. Weber - East Hanover NJ, US Leonard S. Scarola - East Hanover NJ, US Vinay Bhatnagar - East Hanover NJ, US
A package includes a first pouch and either a second pouch or a cover, where the pouches are configured to contain a product, such as a food product, and attached relative to each other about a hinge. The package includes at least one closure flap. The first and second pouches or first pouch and cover are movable about the hinge from a closed position where access is at least partially blocked by the closure flap when in the closed position and wherein the closure flap is separated to allow greater access when in an open position. Methods of manufacturing such packages are also provided.
Package Opening Feature And Methods Of Manufacturing Same
Flexible film packages having an easily opened package feature incorporated therein and method of producing such packages are provided. The package opening feature may be incorporated into a variety of package formats such as flow wrapped packages having a longitudinal seal (including fin seals or lap seals) or packages with side seals (including two-, three-, or four-side seal pouches). In one illustrative approach, the package opening feature is disposed adjacent or at a package seal, such as, for example, an end seal, a top seal, a bottom seal, a side seal, or a longitudinal seal. The flexible film laminate has at least first and second film layers, and at least one of the film layers defining an interior cavity configured to hold food products. In a number of configurations, the flexible film packages may be reclosable or resealable.
- East Hanover NJ, US Gladys Odette Moncayo - Woodbridge NJ, US Jeffrey Thomas Weber - Lake Zurich IL, US Elizabeth A. McDermott - Verona NJ, US Douglas H. Philipsen - Hackettstown NJ, US
International Classification:
B65D 75/52
Abstract:
A resealable closure for packages is provided which has a package integrity feature. The closure includes a two-ply material having an inner film layer and an outer film layer, forming a top of container. The outer film layer has a sealing panel completely covering a first panel and a second panel of the inner film layer. The sealing panel is permanently attached to the first panel and is releasably affixed a portion of the inner film layer around the perimeter of the first panel to form an opening in the top when the sealing panel with affixed first panel is peeled back from the top. The sealing panel is resealable against the top to seal the opening when the sealing panel is moved back against the top. The package integrity feature comprises the second panel of the inner layer which separates from the sealing panel to indicate that the container has been previously opened.
For covid-19 patients, cytokine storms are a major reason that some require intensive care and ventilation, said Jeffrey Weber, deputy director of the Perlmutter Cancer Center at NYU Langone Medical Center.
Date: Apr 15, 2020
Category: More news
Source: Google
New clinical trial might change the standard treatment for melanoma
Results like this will change how we practice medicine, said Jeffrey Weber, a professor of medicine at NYU Langone School of Medicine, who presented the findings at the annual meeting of the European Society for Medical Oncology in Madrid. The results were published simultaneously online in the Ne
"This is clearly an outstanding science result that sets the scene for the further development of the test to quantify [immune biomarkers] in different malignancies," said Dr. Jeffrey Weber, an immunologist and oncologist at the Moffitt Cancer Center in Tampa, Fla., who was
"It's the first in a series of targeted drugs, meaning it's a drug that targets a specific mutation in about half of all melanomas that begin on the skin," said Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at the H. Lee Moffitt Cancer Center. "It's really imp
Date: Aug 21, 2011
Category: Health
Source: Google
New melanoma drug had trial run at Moffitt Cancer Center
Dr. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt, was an investigator on a Phase II student that enrolled 132 patients. The study showed that vemurafenib (pronounced vem-yoo-RAF-en-ib) shrank tumors in 52 percent of trial participants, and participa
Date: Aug 18, 2011
Category: Health
Source: Google
Youtube
Cancer Revealed: How the Immune System Sees a...
On June 16, 2015, Jeffrey S. Weber, M.D., Ph.D., discussed the cancer ...
Duration:
1h 2m 36s
Meet Oncologist Dr. Jeffrey Weber
NYU Langone oncologist Dr. Jeffrey Weber is a specialist in melanoma m...
Duration:
2m 21s
Dr Jeffrey Weber explains his approach to imm...
Drs Jeffrey Weber and Khalid Jazieh discuss immunotherapy-in... colit...
Duration:
10m 9s
How to manage chronic non-cutaneous immune-re...
Jeffrey Weber, MD, PhD, NYU Langone Medical Center, New York, NY, disc...
Duration:
5m 25s
Jeffrey Weber Explains Organ-Specific Side Ef...
Jeffrey Weber, MD, PhD, from NYU Langone Perlmutter Cancer Center expl...
Duration:
1m 51s
Dr. Jeffrey Weber on Optimal Therapy Sequence...
Jeffrey S. Weber, MD, PhD, the director of the Donald A. Adam Comprehe...
University of Louisville - Electrical Engineering, Atherton High School
About:
I now own my own company Frozen Mercury Productions, I hope it's the start of something amazing. I am a jack of all trades I know something about everything, and am willing to share all my knowled...
Tagline:
Jeffrey Arra Weber
Jeffrey Weber
Work:
Booz Allen Hamilton
Education:
Virginia Polytechnic Institute and State University